EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The structural basis of IL-36R proinflammatory signaling mediated by IL-36γ and IL-37

Julie Andries, Martin Toul, Lisse Thierens, Brecht Bekaert, Jan Felix, Danielle M. Clancy, Savvas N. Savvides

Science Immunology · 2026-11-06 · 11 (125)

DOI: 10.1126/sciimmunol.adw5770 ↗
AbstractBibliografische Angaben

Abstract

The interleukin-36 receptor (IL-36R) drives proinflammatory signaling and is therapeutically targeted by spesolimab in acute skin inflammation. Beyond its three canonical agonists (IL-36α, IL-36β, and IL-36γ), IL-36R was recently proposed to be activated by IL-37. Together with antagonism by IL-36R antagonist (IL-36RA) and IL-38, this creates a complex structure-function landscape that remains poorly understood. Here, we report the cryo–electron microscopy (cryo-EM) structure of human IL-36γ bound to IL-36R and the shared co-receptor IL-1R accessory protein (IL-1RAcP). IL-36γ engages IL-36R with low affinity, enabling high-affinity IL-1RAcP recruitment. IL-37 exhibits the opposite binding signature, binding IL-36R with high affinity but IL-1RAcP weakly. Functional comparison of IL-36R engagement by IL-36γ and IL-37 confirmed their common proinflammatory signature, with IL-36γ exhibiting markedly higher potency, consistent with its more stable signaling complex. Structural comparison of cytokine-bound versus antibody-antagonized IL-36R revealed that spesolimab acts as an allosteric antagonist. This study therefore provides a structural and mechanistic blueprint for IL-36R activation by distinct cytokines.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →